{{Rsnum
|rsid=416603
|Gene=TNP2
|Chromosome=16
|position=11270222
|Orientation=plus
|GMAF=0.3815
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=TNP2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 33.6 | 42.5 | 23.9
| HCB | 67.2 | 29.2 | 3.6
| JPT | 80.5 | 18.6 | 0.9
| YRI | 24.0 | 52.1 | 24.0
| ASW | 21.1 | 49.1 | 29.8
| CHB | 67.2 | 29.2 | 3.6
| CHD | 65.1 | 28.4 | 6.4
| GIH | 28.7 | 56.4 | 14.9
| LWK | 20.9 | 58.2 | 20.9
| MEX | 8.6 | 53.4 | 37.9
| MKK | 18.6 | 49.4 | 32.1
| TSI | 27.5 | 46.1 | 26.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=18978792
|Trait=Type 1 diabetes
|Title=Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci
|RiskAllele=T
|Pval=0.0000030000000000000001
|OR=1.06
|ORtxt=[1.01-1.12]
|OA=1
}}

{{PharmGKB
|RSID=rs416603
|Name_s=
|Gene_s=PRM3, TNP2
|Feature=
|Evidence=PubMed ID:18978792; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. (Initial Sample Size: 3,561 cases, 4,646 controls; Replication Sample Size: 6,225 cases, 6,946 controls, 3,064 trios); (Region: 16p13.13; Reported Gene(s): C16orf75, PRM3, TNP2; Risk Allele: rs416603-T); (p-value= 0.000003).This variant is associated with Type 1 diabetes.
|Drugs=
|Drug Classes=
|Diseases=Diabetes Mellitus; Diabetes Mellitus, Type 1
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740762
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs416603
|overall_frequency_n=62
|overall_frequency_d=128
|overall_frequency=0.484375
|n_genomes=36
|n_genomes_annotated=0
|n_haplomes=52
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}